Bristol-Myers Squibb (BMY -0.1%) is due to begin talks today to resolve hundreds of millions of...

|About: Bristol-Myers Squibb Company (BMY)|By:, SA News Editor

Bristol-Myers Squibb (BMY -0.1%) is due to begin talks today to resolve hundreds of millions of dollars in claims in cases of people who died or became ill after participating in testing for the company's hepatitis C treatment 094. Bristol stopped developing the drug in August and took a $1.8B charge after a patient died during the trial and others had to go to hospital.